ICLR (US) share price forecast & AI signal — ICON Public Limited Company
Week of 2026-10-30 · Healthcare
Exact confidence, 1-week / 1-month / 3-month breakdown, plain-English AI write-up, bull-vs-bear debate, support & resistance.
Get 5 free tokens — no card Already a member? Open the full analysisWhat the model sees in ICLR
ICON Public Limited Company is a Healthcare stock listed on the US. For the week of 2026-10-30 the ACE machine-learning model rates it a HOLD with high confidence, based on technical indicators and the stock's own historical patterns across three time horizons. The direction is updated every model run.
About ICON Public Limited Company
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development...
Recent closes
| Date | Close |
|---|---|
| 2026-11-06 | $204.74 |
| 2026-11-05 | $201.65 |
| 2026-11-04 | $203.11 |
| 2026-11-03 | $203.77 |
| 2026-11-02 | $205.14 |
| 2026-10-30 | $211.36 |
| 2026-10-29 | $215.48 |
ICLR FAQ
Is ICON Public Limited Company (ICLR) a buy or sell this week?
The ACE Stock Bots machine-learning model rates ICLR a HOLD for the week of 2026-10-30 with high confidence. The exact confidence and the 1-week, 1-month and 3-month breakdown are free with a signup (5 analysis tokens, no card).
What is the AI share price forecast for ICLR?
Every week the model scores ICLR across three horizons using technical indicators and the stock's own historical patterns. An AI then writes a plain-English summary with support and resistance levels, and a bull analyst and a bear analyst argue the case.
Is this financial advice?
No. ACE Stock Bots provides general information generated by software. It does not consider your objectives, financial situation or needs. Read the disclaimer and consider licensed advice before acting.
Other Healthcare stocks on the US
This week's top US picks · All US stocks
Signals are generated by software for general information only and are not a recommendation to buy or sell. See the disclaimer.